Biomarker News and Research

RSS
A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.
Penn Medicine selected as study site for PPMI

Penn Medicine selected as study site for PPMI

AccuPSA test for detecting prostate cancer recurrence

AccuPSA test for detecting prostate cancer recurrence

Unique genetic markers point to patient response to SCV-07 treatment

Unique genetic markers point to patient response to SCV-07 treatment

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

Circulating tumor cells may be promising alternative for tumor biopsies

Circulating tumor cells may be promising alternative for tumor biopsies

KINAXO, Daiichi Sankyo enter long-term partnership in cancer research

KINAXO, Daiichi Sankyo enter long-term partnership in cancer research

Researchers identify biomarker to predict tivozanib drug resistance

Researchers identify biomarker to predict tivozanib drug resistance

Loss of INPP5A gene can predict cutaneous squamous cell carcinoma progression

Loss of INPP5A gene can predict cutaneous squamous cell carcinoma progression

Researchers discover new diagnostic test for prostate cancer

Researchers discover new diagnostic test for prostate cancer

Triple-negative breast cancer patients may have unique biomarker to receive targeted therapy: Research

Triple-negative breast cancer patients may have unique biomarker to receive targeted therapy: Research

NCI awards A&G $1.2M Phase II SBIR grant for development of breast cancer drug candidate

NCI awards A&G $1.2M Phase II SBIR grant for development of breast cancer drug candidate

Family members, friends are more sensitive to early signs of Alzheimer's dementia: Researchers

Family members, friends are more sensitive to early signs of Alzheimer's dementia: Researchers

NPL, Orla receives fund to improve detection methods for TB

NPL, Orla receives fund to improve detection methods for TB

Michael J. Fox Foundation launches PPMI clinical study to identify Parkinson's disease biomarkers

Michael J. Fox Foundation launches PPMI clinical study to identify Parkinson's disease biomarkers

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

BMC physicians to lead international research collaboration to curb infectious diseases

BMC physicians to lead international research collaboration to curb infectious diseases

Clinical Data announces Stedivaze agonist data at ASNC2010 meeting

Clinical Data announces Stedivaze agonist data at ASNC2010 meeting

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

CIC proposes criteria to improve endpoints for cancer immunotherapy trials

CIC proposes criteria to improve endpoints for cancer immunotherapy trials

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.